Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Paclitaxel is a vital chemotherapy drug, but cancer cells often develop resistance, limiting treatment success.
• Circular RNAs (circRNAs) are increasingly recognized as critical players in regulating this chemoresistance.

Purpose of the Study:

• To review and synthesize current knowledge on how circRNAs mediate paclitaxel resistance.
• To categorize circRNAs as promoters or suppressors of chemoresistance and explore their underlying mechanisms.

Main Methods:

• Literature review and synthesis of existing research on circRNAs and paclitaxel resistance.
• Analysis of circRNA regulatory pathways, including miRNA sponging and protein interactions.
• Focus on downstream effects like epithelial-mesenchymal transition and autophagy modulation.

Main Results:

• CircRNAs influence paclitaxel sensitivity through miRNA sponging and protein interactions.
• Epithelial-mesenchymal transition and autophagy are significant downstream pathways affected by circRNAs.
• Certain circRNAs exhibit dual roles, acting as promoters or suppressors depending on the cancer type.

Conclusions:

• CircRNA mechanisms are complex and context-dependent, necessitating tissue-specific therapeutic strategies.
• Further research into circRNA regulatory networks and standardized profiling is essential for clinical translation.
• CircRNAs hold promise as biomarkers and targets for overcoming paclitaxel resistance in personalized oncology.